Comera Life Sciences Holdings, Inc.
CMRA
$0.0001
$0.000.00%
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | 47.21% | 33.35% | -125.78% | -230.24% | -- |
| Total Depreciation and Amortization | 5.83% | 12.14% | 10.05% | 9.18% | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -84.84% | -83.77% | 376.07% | 440.58% | -- |
| Change in Net Operating Assets | -26.25% | 26.43% | 723.03% | 344.36% | -- |
| Cash from Operations | 30.09% | 11.59% | -43.53% | -160.03% | -- |
| Capital Expenditure | 40.89% | 18.01% | 17.54% | 79.79% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 40.89% | 18.01% | 17.54% | 79.79% | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -93.27% | -- | -- | -- | -- |
| Issuance of Common Stock | 26.58% | -30.87% | 950.85% | 2,565.11% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 927.69% | -- | -- |
| Cash from Financing | 42.36% | -55.36% | -32.32% | -49.00% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 83.83% | -127.57% | -166.92% | -171.44% | -- |